BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15964564)

  • 1. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
    Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
    Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
    Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
    Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
    de Berrazueta JR; Sampedro I; Garcia-Unzueta MT; Llorca J; Bustamante M; Amado JA
    Am Heart J; 2003 Oct; 146(4):E14. PubMed ID: 14564337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
    Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
    Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M; Bosse S; Oltmanns U; Schumacher A; Witt C
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose theophylline on airway inflammation in COPD.
    Kobayashi M; Nasuhara Y; Betsuyaku T; Shibuya E; Tanino Y; Tanino M; Takamura K; Nagai K; Hosokawa T; Nishimura M
    Respirology; 2004 Jun; 9(2):249-54. PubMed ID: 15182277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care].
    Faber M; Jahnz-Rózyk K; Kucharczyk A; Targowski T; From S; Mamełka B
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():96-9. PubMed ID: 15524029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit.
    Hsieh LC; Chien SL; Huang MS; Tseng HF; Chang CK
    Asia Pac J Clin Nutr; 2006; 15(4):544-50. PubMed ID: 17077073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serum amyloid A response to sterile silver nitrate in mice and its inhibition by dexamethasone and macrolide antibiotics.
    Glojnaric I; Cuzic S; Erakovic-Haber V; Parnham MJ
    Int Immunopharmacol; 2007 Dec; 7(12):1544-51. PubMed ID: 17920531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
    Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
    Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.